Clinical Trials Directory

Trials / Completed

CompletedNCT06959927

Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
170 (actual)
Sponsor
Guiren Hou · Other Government
Sex
All
Age
38 Years – 68 Years
Healthy volunteers
Not accepted

Summary

Age, hyperglycemia, inflammation, and comorbidities (hypertension, diabetes, coronary disease) independently increase HF risk in hemodialysis patients. Targeted risk management reduces psychological distress, complications, and enhances care outcomes.

Detailed description

To identify risk factors for heart failure (HF) in hemodialysis patients and assess the efficacy of targeted risk management strategies in improving prognosis and care quality. A total of 170 hospitalized dialysis patients from January 2022 to January 2024 were enrolled. They were divided into two groups based on the presence or absence of heart failure: the heart failure group (n=80) and the non-heart failure group (n=90). The inducing factors were analyzed, and targeted risk management strategies were implemented, with the participants further divided into a conventional group (n=40) and a study group (n=40) to explore the effect of these strategies.

Conditions

Interventions

TypeNameDescription
OTHERStandard Care GroupPatients in this group received conventional hemodialysis care, including: Continuous monitoring of vital signs (blood pressure, respiratory rate, pulse, heart rhythm); Supplemental oxygen therapy as needed; Instruction on effective coughing techniques; Strict fluid and electrolyte management; Metabolic support therapies; Positional adjustments (upright posture with lower limb dependency); Environmental regulation (temperature: 22-24°C; humidity: 50-60%); Individualized dietary counseling.
OTHERRisk-Stratified Management GroupPatients in this group received standard care plus targeted risk management interventions: System Enhancement: Standardized nursing protocols and accountability frameworks Competency-based staff training (emergency response, fluid management) Individualized care plans (e.g., intensified glycemic control for diabetics, optimized BP monitoring for hypertensives) Risk Stratification: Admission assessments and follow-up evaluations to identify high-risk patients Hemodynamic monitoring with alert thresholds for early deterioration detection Strict pharmacological supervision and fluid balance protocols Environmental Modification: Optimized dialysis unit conditions (temperature: 22-24°C; humidity: 50-60%) Dedicated cardiac care zones for HF patients Quality Control: Quarterly audits of critical care domains (patient education, vital signs documentation, protocol compliance, satisfaction metrics) Corrective actions for identified deficiencies

Timeline

Start date
2022-01-01
Primary completion
2024-01-01
Completion
2024-01-30
First posted
2025-05-07
Last updated
2025-05-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06959927. Inclusion in this directory is not an endorsement.